Kidney Function Markers and Biological Age

Key Takeaways

Kidney function markers are common in biological-age research because renal filtration, vascular health, inflammation, and metabolic homeostasis change with ageing. [1] [2]
Creatinine-based eGFR is widely used, but creatinine is influenced by muscle mass, diet, and body composition, which are themselves age-related. [3] [4]
Cystatin C often provides stronger risk stratification in older adults, but it is not a pure ageing marker and can also reflect inflammation, adiposity, smoking, and disease burden. [5] [6]
Albuminuria adds information about kidney damage and vascular risk that is not captured by filtration alone. [7] [8]

Kidney function markers appear in ageing research because the kidney is central to filtration, fluid balance, acid-base regulation, mineral metabolism, endocrine signaling, and clearance of many small molecules. Lower renal reserve can therefore influence blood chemistry, cardiovascular risk, inflammatory burden, and the interpretation of other biomarkers used in biological-age models. [1] [2] [9]

Who This Is Useful For

This page is useful for readers trying to understand why creatinine, eGFR, cystatin C, and albuminuria often appear beside biological-age estimates, frailty measures, mortality models, and multimorbidity studies. It is especially relevant when a biological-age calculator uses creatinine directly, when two eGFR equations disagree, or when a kidney-related result is being interpreted as a general ageing signal. [4] [5] [10]

What Kidney Function Markers Measure

Estimated glomerular filtration rate, or eGFR, is usually derived from serum creatinine, cystatin C, or both. It estimates how efficiently the kidneys filter small solutes from blood, but it is still an estimate rather than a direct measured filtration test. Equations combining creatinine and cystatin C were developed because each marker carries different non-GFR influences. [3] [4]

Albuminuria, usually expressed as a urine albumin-to-creatinine ratio, measures leakage of albumin into urine. It is often interpreted as a sign of kidney damage, endothelial dysfunction, or vascular stress, and it predicts outcomes independently of eGFR in large population analyses. [7] [8]

Common Markers at a Glance

Marker	What It Mainly Represents	Why It Appears in Ageing Research	Main Interpretation Limit
Serum creatinine	Creatinine generation and renal clearance	Used directly in some clinical biological-age models and indirectly through eGFR [10]	Strongly affected by muscle mass, diet, and body size [3] [4]
Creatinine-based eGFR	Estimated filtration from creatinine, age, and sex	Summarizes kidney filtration in routine datasets and epidemiological cohorts [4]	Can misclassify risk when creatinine is distorted by non-kidney factors [5]
Cystatin C-based eGFR	Estimated filtration using a low-molecular-weight protein	Often improves risk classification in older adults and lower-muscle states [5] [6]	Still influenced by non-GFR factors such as inflammation and adiposity [6]
Albuminuria	Urinary albumin leakage and kidney or vascular damage	Adds prognostic information beyond filtration alone [7] [8]	Can vary with exercise, infection, glycemia, blood pressure, and sampling context [8]
Beta-2 microglobulin and beta-trace protein	Alternative low-molecular-weight filtration markers	Used in research to study filtration and prognosis beyond creatinine [11] [12]	Less standardized for routine biological-age interpretation [12]

Why Kidney Markers Relate to Biological Age

Kidney structure and function change across adulthood, with ageing kidneys often showing nephron loss, glomerulosclerosis, vascular narrowing, tubular atrophy, and fibrosis. These changes can reduce filtration reserve and alter the handling of electrolytes, acid-base balance, mineral metabolism, and many circulating metabolites. [1] [2]

Because biological-age models often aim to summarize mortality risk, physiological reserve, or multisystem dysregulation, kidney markers can contribute signal even when they are not intended to measure renal ageing specifically. Phenotypic Age, for example, includes creatinine among nine clinical biomarkers selected for mortality prediction, making kidney-related chemistry one component of a wider risk model rather than a standalone biological-age measure. [10] [13]

Creatinine and the Muscle-Mass Problem

Creatinine is produced from muscle metabolism and cleared partly through kidney filtration, which makes it useful but also vulnerable to confounding. Older adults, people with low muscle mass, and people with unusually high muscle mass can have creatinine values that do not map cleanly onto true filtration. [3] [4]

This is important for biological-age interpretation because muscle mass itself changes with ageing and health status. A low creatinine value can sometimes reflect low muscle production rather than strong kidney function, while a higher value can reflect greater muscle mass or creatine intake rather than impaired filtration. The marker is therefore informative only when interpreted with body composition, clinical context, and, when available, other kidney markers. [4] [5]

Cystatin C and Risk Stratification

Cystatin C is produced by nucleated cells and filtered by the glomerulus, so it is less directly tied to muscle mass than creatinine. In large pooled analyses, cystatin C-based eGFR improved risk classification for death and end-stage renal disease compared with creatinine-based eGFR alone. [5]

In older adults, cystatin C has also been associated with mortality, disability, and successful ageing outcomes. This does not mean cystatin C is a pure biological-age measure. Studies of non-GFR determinants show that inflammation, obesity, smoking, diabetes, and other clinical factors can affect cystatin C and related low-molecular-weight proteins. [6] [14]

Albuminuria and Vascular-Ageing Context

Albuminuria captures a different dimension from filtration. It can reflect kidney barrier injury, glomerular pressure, endothelial dysfunction, diabetes, hypertension, or broader vascular pathology. This is why eGFR and albuminuria are often evaluated together rather than treated as interchangeable kidney measures. [7] [8]

In general population cohorts, lower eGFR and higher albuminuria were independently associated with all-cause and cardiovascular mortality. For ageing research, that combination matters because it links kidney markers with systemic risk rather than only organ-specific disease classification. [7]

Links With Molecular Ageing Measures

Kidney traits also intersect with molecular ageing measures. A large trans-ethnic meta-analysis found that several DNA methylation age-acceleration and mortality signatures were associated with lower eGFR, higher urine albumin-to-creatinine ratio, microalbuminuria, prevalent chronic kidney disease, and higher serum urate. [15]

This does not prove that kidney dysfunction causes accelerated epigenetic ageing, or that epigenetic ageing causes kidney decline. It shows that kidney health and molecular ageing signatures overlap in population data, likely through a mixture of inflammation, vascular disease, metabolic stress, cellular composition, and renal physiology. [9] [15]

Evidence Quality and Interpretation

Confidence is strong that eGFR and albuminuria predict mortality and cardiovascular outcomes in large cohorts, and that cystatin C can improve risk stratification in many settings where creatinine is limited. [5] [7] [8]

Confidence is moderate that kidney function markers contribute meaningful information to biological-age models, because they capture renal reserve, vascular risk, and systemic physiology. Their contribution is model-dependent, however, and should not be treated as a direct measurement of whole-body ageing. [10] [13]

Confidence is weaker for interpreting a single creatinine, cystatin C, eGFR, or albuminuria value as a standalone biological-age score. Each marker has non-ageing influences, and many kidney measures are affected by hydration, acute illness, medication use, body composition, sampling conditions, and the equation or assay used. [4] [6]

What This Does Not Mean

It does not mean a kidney marker is equivalent to a whole-body biological-age measure. [10] [13]
It does not mean creatinine-based eGFR and cystatin C-based eGFR should always agree. [5] [6]
It does not mean albuminuria measures filtration; it captures kidney damage and vascular risk information that can be independent of eGFR. [7] [8]
It does not mean associations between kidney traits and epigenetic clocks establish a single causal pathway. [15]

Practical Interpretation Examples

If creatinine is included in a biological-age calculator: it contributes kidney-related and muscle-related information to the model, not a direct reading of ageing speed. [10] [13]
If cystatin C-based eGFR is lower than creatinine-based eGFR: the difference may reveal risk-relevant physiology, but it also requires attention to non-GFR determinants. [5] [6]
If albuminuria is elevated while eGFR is preserved: that pattern may still carry vascular and kidney-risk information because albuminuria and filtration describe different domains. [7] [8]

Summary

Kidney function markers are important in biological-age research because renal filtration, vascular integrity, body composition, inflammation, and systemic homeostasis are closely connected in later life. Creatinine, cystatin C, eGFR, and albuminuria each capture useful but partial information. Their strongest role is as part of a broader biomarker context, where they help describe physiological reserve and risk without being treated as complete measures of biological age. [5] [7] [10]

References

Denic, A., Glassock, R. J., & Rule, A. D. (2016). Structural and functional changes with the aging kidney. Advances in Chronic Kidney Disease. https://pmc.ncbi.nlm.nih.gov/articles/PMC4693148/
Bolignano, D., Mattace-Raso, F., Sijbrands, E. J. G., & Zoccali, C. (2014). The aging kidney revisited: A systematic review. Ageing Research Reviews. https://pubmed.ncbi.nlm.nih.gov/24280505/
Inker, L. A., et al. (2012). Estimating glomerular filtration rate from serum creatinine and cystatin C. The New England Journal of Medicine. https://www.nejm.org/doi/full/10.1056/NEJMoa1114248
Inker, L. A., et al. (2021). New creatinine- and cystatin C-based equations to estimate GFR without race. The New England Journal of Medicine. https://www.nejm.org/doi/full/10.1056/NEJMoa2102953
Shlipak, M. G., et al. (2013). Cystatin C versus creatinine in determining risk based on kidney function. The New England Journal of Medicine. https://www.nejm.org/doi/full/10.1056/NEJMoa1214234
Foster, M. C., et al. (2017). Non-GFR determinants of low-molecular-weight serum protein filtration markers in the elderly: AGES-Kidney and MESA-Kidney. American Journal of Kidney Diseases. https://pmc.ncbi.nlm.nih.gov/articles/PMC5572311/
Chronic Kidney Disease Prognosis Consortium. (2010). Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality. The Lancet. https://pmc.ncbi.nlm.nih.gov/articles/PMC3993088/
Matsushita, K., et al. (2015). Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: A collaborative meta-analysis. The Lancet Diabetes & Endocrinology. https://pubmed.ncbi.nlm.nih.gov/26028594/
Kooman, J. P., et al. (2014). Chronic kidney disease and premature ageing. Nature Reviews Nephrology. https://pubmed.ncbi.nlm.nih.gov/24686460/
Levine, M. E., et al. (2018). An epigenetic biomarker of aging for lifespan and healthspan. Aging. https://pmc.ncbi.nlm.nih.gov/articles/PMC5940111/
Juraschek, S. P., et al. (2013). Comparison of serum concentrations of beta-trace protein, beta-2 microglobulin, cystatin C, and creatinine in the US population. Clinical Journal of the American Society of Nephrology. https://pmc.ncbi.nlm.nih.gov/articles/PMC3613960/
Bachmann, L. M., et al. (2017). Beta trace protein does not outperform creatinine and cystatin C in estimating glomerular filtration rate in older adults. Scientific Reports. https://pmc.ncbi.nlm.nih.gov/articles/PMC5627233/
Kwon, D., Belsky, D. W., & Achenbach, C. J. (2021). A toolkit for quantification of biological age from blood chemistry and organ function test data: BioAge. GeroScience. https://pmc.ncbi.nlm.nih.gov/articles/PMC8602613/
Sarnak, M. J., et al. (2008). Cystatin C and aging success. Archives of Internal Medicine. https://pmc.ncbi.nlm.nih.gov/articles/PMC2871318/
Matias-Garcia, P. R., et al. (2021). DNAm-based signatures of accelerated aging and mortality in blood are associated with low renal function. Clinical Epigenetics. https://clinicalepigeneticsjournal.biomedcentral.com/articles/10.1186/s13148-021-01082-w

Educational Disclaimer

This content is provided for educational purposes only and does not constitute medical advice.